A 1-2 punch: Embryonic cell and adult pig islet transplants cure diabetes in rats

June 29, 2010, Washington University School of Medicine

In a step toward curing diabetes in humans, scientists at Washington University School of Medicine in St. Louis have alleviated the disease in rats using transplants from both embryonic and adult pigs.

The rats adopted the pig transplants as their own and produced enough insulin to control their blood sugar - all without the need for anti-rejection drugs. The researchers report their findings online in the .

Using a two-step approach, the researchers first transplanted a cluster of embryonic pig pancreatic cells into diabetic rats. These cells grow to become the pancreas, which houses the islet cells that produce insulin. The primed the rats' immune system to accept a second implant of islets from adult pigs several weeks later.

The new research - the first long-term, successful cross-species transplant of pig islets without immune suppression - raises the prospect that it may one day be possible to cure diabetes in humans using a similar strategy. Pig cells could overcome the shortage of human islets available from deceased donors and the need for transplant patients to take anti-rejection drugs for life.

"While human islet transplants have cured diabetes in some people, there are so few donors that only a small percentage of patients get transplants," says senior author Marc Hammerman MD, the Chromalloy Professor of Renal Diseases in Medicine. "Moreover, those who receive human islet transplants must take anti-rejection drugs for the rest of their lives, so essentially they are trading daily insulin shots for immune-suppression drugs, which carry their own risks. Our research paves the way for a new approach to treating diabetes, one that features a virtually unlimited supply of islets and no need for immune suppression."

Pig insulin has been used to treat diabetes in humans, making the animals potentially good islet donors for humans with the disease. Insulin from pigs was routinely given to patients with diabetes until the 1980s, when DNA technology enabled pharmaceutical companies to manufacture human insulin.

In the new study, the researchers transplanted clusters of embryonic pig pancreatic cells into 10 diabetic rats that could not produce any insulin on their own and had very high glucose levels. The cells were retrieved from the pig embryos early in their development, which is believed to make them "invisible" to the rats' immune system or induce a state of immune tolerance.

As the immature pancreatic cells developed, they began to produce insulin, significantly lowering blood glucose in the rats, though not to normal levels. Then, eight weeks later, some of the rats underwent a second transplant of islet cells from adult pigs. Other diabetic rats in a control group did not receive any embryonic pancreatic cells but only adult pig islets.

After 12 weeks and for the several months that followed, the rats that got both the embryonic pig pancreatic cells and the islets had normal blood glucose levels, a strong indicator that the pig islet cells were producing ample insulin. The rats in the control group that received only embryonic pancreatic cells continued to have higher-than-normal glucose levels.

The researchers determined by multiple methods that the successfully transplanted pig islets had become established in the rats that had earlier received embryonic pancreatic cell transplants. In contrast, the pig underwent immune rejection in the rats that did not get the embryonic pancreatic cell transplants.

"This is a major advance and a completely new way to employ pig islets for the treatment of diabetes," Hammerman says. "In essence, first transplanting embryonic pig pancreatic cells enables adult pig islet implants to cure diabetes in rats without immune suppression drugs. We are now carrying out experiments to test whether the same transplant strategy works in diabetic non-human primates without using immune suppression drugs. If it does, we hope to evaluate pig cell transplants in people with diabetes."

In earlier research, Hammerman and his colleagues demonstrated they could cure diabetes in rats using larger quantities of embryonic pig pancreatic cell clusters alone, without the need for immune suppression drugs. But they hit a roadblock when they attempted the same transplant procedure in non-human primates. The embryonic pig engrafted in the primates and lowered their blood sugar levels but not enough to wean the animals completely off insulin injections.

"Primates are much larger than rats, and we learned we would need to give them massive amounts of embryonic pig pancreatic tissues, which is not practical," Hammerman says. "Adult pig islets provide a more concentrated source of insulin and are easier to obtain. We are hopeful their ability to effectively control blood sugar levels in rats without an immune suppression requirement will carry over to non-human primates and eventually to humans."

Hammerman and lead author Sharon Rogers, research instructor of medicine, are leaders in the emerging field of organogenesis, which focuses on growing organs from stem cells and other embryonic cell clusters known as organ primordia. Unlike stem , which can become virtually any cell type, primordia are locked into becoming a particular cell type or set of cell types that make up an organ.

More information: Rogers SA, Mohanakumar T, Liapis H, Hammerman MR. Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in non-immune suppressed diabetic rats. American Journal of Pathology. DOI:10.2353/ajpath.2010.091193 June 2010.

Related Stories

Recommended for you

Breakthrough article on mechanistic features of microRNA targeting and activity

March 23, 2018
Giovanna Brancati and Helge Grosshans from the FMI have described target specialization of miRNAs of the let-7 family. They identified target site features that determine specificity, and revealed that specificity can be ...

Calorie restriction trial in humans suggests benefits for age-related disease

March 22, 2018
One of the first studies to explore the effects of calorie restriction on humans showed that cutting caloric intake by 15% for 2 years slowed aging and metabolism and protected against age-related disease. The study, which ...

Boosting enzyme may help improve blood flow, fitness in elderly

March 22, 2018
As people age, their blood-vessel density and blood flow decrease, which is why it's harder to maintain muscle mass after 40 and endurance in the later decades, even with exercise. This vascular decline is also one of the ...

Scientists pinpoint cause of vascular aging in mice

March 22, 2018
We are as old as our arteries, the adage goes, so could reversing the aging of blood vessels hold the key to restoring youthful vitality?

Sulfur amino acid restriction diet triggers new blood vessel formation in mice

March 22, 2018
Putting mice on a diet containing low amounts of the essential amino acid methionine triggered the formation of new blood vessels in skeletal muscle, according to a new study from Harvard T.H. Chan School of Public Health. ...

Cold can activate body's 'good' fat at a cellular level, study finds

March 21, 2018
Lower temperatures can activate the body's 'good' fat formation at a cellular level, a new study led by academics at The University of Nottingham has found.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.